Proud to see our @ignigor presenting a poster about the therapeutic impact and reactivation of tumor immunity by MYC inhibition in KRAS-driven NSCLC with diverse mutational profiles at the #EACR Congress: Defence is the best attack: Immuno-Oncology Breakthroughs 2025. Great work!